{"filing":{"accession_number":"0001683168-26-004707","cik":"0000882291","ticker":"AEMD","company_name":"AETHLON MEDICAL INC","form":"8-K","filing_date":"2026-06-10","report_date":null,"primary_document":"aethlon_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316826004707/aethlon_8k.htm"},"events":[{"id":5796,"run_id":5081,"accession_number":"0001683168-26-004707","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses financial results for the quarter ended March 31, 2026, via a press release issued on June 10, 2026 and furnished as Exhibit 99.1. This is a standard quarterly earnings release disclosure under Item 2.02, which is material to investors assessing the registrant's operational and financial performance.","company_name":"AETHLON MEDICAL INC","ticker":"AEMD","filing_date":"2026-06-10","form":"8-K","submitted_at":null,"items":[{"id":5869,"accession_number":"0001683168-26-004707","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses financial results for the quarter ended March 31, 2026, via a press release issued on June 10, 2026 and furnished as Exhibit 99.1. This is a standard quarterly earnings release disclosure under Item 2.02, which is material to investors assessing the registrant's operational and financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-10T20:17:36.494181+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5869,"accession_number":"0001683168-26-004707","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses financial results for the quarter ended March 31, 2026, via a press release issued on June 10, 2026 and furnished as Exhibit 99.1. This is a standard quarterly earnings release disclosure under Item 2.02, which is material to investors assessing the registrant's operational and financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-10T20:17:36.494181+00:00","company_name":"AETHLON MEDICAL INC","ticker":"AEMD","filing_date":"2026-06-10"}]}